Links

Measles outbreak expands to 19 states.Commercial health plan coverage of accelerated approval drugs…and a recent case study.Extending IRA drug price negotiation to commercial plans?‘Kennedy Turns to a Discredited Vaccine Skeptic for Autism Study’Why are LLMs so good at economics?Most expensive states to start a business.

Read More

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2022

This analysis examines the competitiveness of markets for hospital care based on the share of metropolitan areas controlled by a small number of independent hospitals or health systems and other measures. It finds that nearly half of metropolitan areas across the country had only one or two hospitals or health systems providing general inpatient hospital…

Read More

Administration Releases Additional Details of Fiscal Year 2026 Budget Request

On May 30, 2025, the administration released additional details of its Fiscal Year 2026 budget request, including more specific information on funding for global health activities at the State Department, U.S. Agency for International Development (USAID), Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH). The proposed budget includes significant…More

Read More

Merck KGaA’s Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition

SpringWorks Therapeutics brings to Merck KGaA two FDA-approved drugs, both currently under regulatory review in Europe. Beyond their initial applications in rare tumors, these small molecules are also being studied as monotherapies and as part of combinations treatments for certain cancers. The post Merck KGaA’s Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition appeared…

Read More